This report provides exclusive insights into the COVID-19 impact on the Cognitive and Memory Enhancer Drugs Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Cognitive and Memory Enhancer Drugs Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Cognitive and Memory Enhancer Drugs Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on cognitive and memory enhancer drugs market provides an in-depth analysis of segments and sub-segments in the global as well as regional cognitive and memory enhancer drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cognitive and memory enhancer drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cognitive and memory enhancer drugs market. According to the report, the global cognitive and memory enhancer drugs market is projected to grow at a CAGR of 8.4% over the forecast period of 2018-2024.
Cognitive and memory enhancer are drugs that are used to increase mental alertness, concentration, and improve memory, as well as to boost energy levels and insomnia. Different types of cognitive enhancers are available. Patients suffering from diseases such as alzheimer’s diseases, stroke, schizophrenia, attention deficit hyperactivity disorder, and aging majorly use cognitive enhancers. Some pharmaceutical drugs used to improve attention and focus, and conditions such as sleepiness or narcolepsy. Some drugs can cause dependence and their effects only last as long as the drug remains in the body. Few drugs may have a range of side effects particularly to young people because their brains continue to develop into their mid-twenties.
Increasing prevalence of neurological disorders such as brain tumors, stroke, dementia, and epilepsy drives the growth of cognitive and memory enhancer drugs market. Benefits offered by cognitive and memory enhancer drugs include improved memory, physical and mental performance, and cognitive function. These offered benefits boost the growth of cognitive and memory enhancer drugs Market. Now a day’s increase in geriatric population leads to the increase in the incidence of alzheimer’s disease therefore, cognitive and memory enhancer drugs are useful to treat alzheimer's disease. However, ethical and authorized security issues regarding cognitive drugs hinder the growth of cognitive and memory enhancer drugs Market. Moreover, ethical and legal safety issues regarding cognitive drugs may hinder the growth of cognitive and memory enhancer drugs Market. Increasing research and development activities regarding drugs and essential strength of the drugs are providing beneficial opportunities for cognitive and memory enhancer drugs Market. In addition, ongoing clinical trials about the benefits and side effects of drugs provide opportunities for cognitive and memory enhancer drugs Market.
Among the geographies, North America dominates the cognitive and memory enhancer drugs market owing to increase in geriatric population and rising number of alzheimer's diseases in the region. According to alzheimer's research UK, around 2 in 100 people elderly 65-69 suffer from dementia. Increasing prevalence of neurological disorders in the region is expected to fuel the growth of cognitive and memory enhancer drugs market. Europe is expected to the second largest region to contribute to the growth of cognitive and memory enhancer drugs market.
The report on global cognitive and memory enhancer drugs market covers segments such as drug type and application. On the basis of drug type, the sub-markets include adderall, provigil, razadyne, aricept, namenda, ritalin, exelon, and others. On the basis of application, the sub-markets include disease treatment, academic performance, athletic performance, and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in this region. The Asia-Pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.
The report provides profiles of the companies in the market such as Eisai Co., Ltd., Pfizer Inc., Johnson & Johnson Services, Inc., Shire, WebMD LLC., Novartis AG, Bayer AG, Takeda Pharmaceutical Company Limited., Allergan, and Sanofi.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cognitive and memory enhancer drugs market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.